India Consults On Aligning Medtech QMS Requirements With ISO 13485
This article was originally published in SRA
The Indian government is inviting stakeholder feedback on proposed quality management system requirements for various types of medical devices and in vitro diagnostics that are formally regulated as drugs under the country's medicines framework1. The draft requirements are based on the international QMS standard ISO 13485:2013 which, when implemented, will bring the regulation of these products in line with the current international practice.
You may also be interested in...
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.